Mark Trusheim

Articles

Aligning Contracting to Solve for Payer Risks Is a Win for Biopharma, Payers, and Patients

Upcoming regulatory changes to create new opportunity for specialized offerings.

Pharmaceutical Executive

Improving Management of Gene and Cell Therapies

An overview of Orphan Reinsurer and Benefit Managers groups, including potential challenges with the model and various model suggestions.